These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 25230249)
1. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant. Mulay S; Kreuter JD; Bryant SC; Elliott MA; Hogan WJ; Winters JL; Gastineau DA J Clin Apher; 2015 Jun; 30(3):147-53. PubMed ID: 25230249 [TBL] [Abstract][Full Text] [Related]
2. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative. Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936 [TBL] [Abstract][Full Text] [Related]
3. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange. Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787 [TBL] [Abstract][Full Text] [Related]
4. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495 [TBL] [Abstract][Full Text] [Related]
5. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin. Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692 [TBL] [Abstract][Full Text] [Related]
6. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review]. Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247 [TBL] [Abstract][Full Text] [Related]
7. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy? Jodele S; Laskin BL; Goebel J; Khoury JC; Pinkard SL; Carey PM; Davies SM Transfusion; 2013 Mar; 53(3):661-7. PubMed ID: 22804695 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. Chapin J; Shore T; Forsberg P; Desman G; Van Besien K; Laurence J Clin Adv Hematol Oncol; 2014 Sep; 12(9):565-73. PubMed ID: 25654478 [TBL] [Abstract][Full Text] [Related]
11. Treatment of thrombotic microangiopathies with plasma exchange. Basic-Jukic N; Kes P; Bubic-Filipi L; Brunetta B Hematology; 2007 Feb; 12(1):63-7. PubMed ID: 17364995 [TBL] [Abstract][Full Text] [Related]
12. [Management of transplant-associated thrombotic microangiopathy]. Ikezoe T Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540 [TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 9 patients with transplant-related thrombotic microangiopathy]. Zhang BL; Zhou J; Gui RR; Zu YL; Zhang YL; Song YP Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):423-427. PubMed ID: 31159520 [No Abstract] [Full Text] [Related]
14. Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange. Xu Y; Wei Y; Wang L; Lu N; Wu Y; Dou L; Liu D; Li M; Gao C Ann Transplant; 2023 Jun; 28():e939890. PubMed ID: 37337423 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis. Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479 [TBL] [Abstract][Full Text] [Related]
16. Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study. Yang LP; Zhao P; Wu YJ; Fu HX; He Y; Mo XD; Lv M; Wang FR; Yan CH; Chen YH; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH Bone Marrow Transplant; 2022 Apr; 57(4):554-561. PubMed ID: 35079139 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study. Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056 [TBL] [Abstract][Full Text] [Related]
18. Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study. Li A; Makar RS; Hurwitz S; Uhl L; Kaufman RM; Stowell CP; Dzik WS; Bendapudi PK Transfusion; 2016 Aug; 56(8):2069-77. PubMed ID: 27232383 [TBL] [Abstract][Full Text] [Related]